Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Part I: to determine the recommended dose of the neoadjuvant regimen of capecitabine, sorafenib and external beam radiotherapy in patients with advanced K-ras mutated rectal cancer. Part IIa: to assess the efficacy and safety of the neoadjuvant regimen of capecitabine, sorafenib and external beam radiotherapy in patients with advanced K-ras mutated rectal cancer.
Critère d'inclusion
- Advanced K-ras mutated rectal cancer